Fundraising FoxHemoSense
1 known investors
Find your way into HemoSense
Sign up to see every warm intro you have to HemoSense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HemoSense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.
Investors · 1
Frequently asked questions
- What does HemoSense do?
- Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.
- Who are HemoSense's investors?
- HemoSense's investors include New Enterprise Associates (NEA).